National Cancer Registry

Definition	A cancer registry is defined as a location, be it an office or institution, where collection, storage, analysis and interpretation of data on cancer patients take place (Jenson et al, 1991).
Objectives	- To measure cancer incidence - To describe cancer by time, place, persons and disease - To provide a national database for further epidemiological research
Case definition	Target cases are: - Incident cases by year of diagnosis - Malignant tumors confirmed by histopathology and/or hematology findings - Cancers of all sites
Sources of data	Data are collected through two main channels: the capture system (passive reporting) and the recapture system (active reporting). 1) The capture system: The capture system is based on physician’s routine reporting of cancer cases. Physician’s complete and send forms: - Directly from their clinic; or - Indirectly through the MOPH Drug Dispensing Center (DDC), where anti-cancer drugs are distributed to eligible patients 2) The recapture system: The recapture system is based on gathering information directly from histopathological and hematological laboratories. Data are collected in various ways, using hard or soft copies, or using database file or individual laboratory results depending on laboratories resources. This process is active since the NCR personnel actually contact the sites to obtain the necessary data. The recapture system validates and complements the capture approach.
Medical coding	The coding of cancer primary sites and cancer morphology is done using International Classification of Diseases for Oncology, third edition (ICD-O-3). The code includes information on the topography (primary site), the histology, the behavior and the grade of the tumor. The structure is C##.# M####/##, where: - C##.# specifies the primary site - M#### specifies the histology - /## specifies the behavior and the grade of the tumor
Reporting form	NCR reporting form

ATC	Name	B/G	Ingredients	Dosage	Form	Price
J01DD04	MEGION	G	Ceftriaxone (disodium 3.5 hydrate) - 1g	1g	Injectable powder for solution+diluent	574,129 L.L
J01DD04	ROCICARE	G	Ceftriaxone - 1g	1g	Injectable powder for solution	9,382,061 L.L
J01DD04	TRAVILAN IM	G	Ceftriaxone (sodium) - 1g	1g	Injectable lyophilised powder for solution+diluent	438,093 L.L
J01DD04	TRIAXONE	G	Ceftriaxone (sodium) - 1g	1g	Injectable powder for solution	438,093 L.L
J01DD04	TRIAXONE	G	Ceftriaxone (sodium) - 1g	1g	Injectable powder for solution	4,542,188 L.L
J01DD04	VERACOL	G	Ceftriaxone (sodium) - 1g	1g	Injectable lyophilised powder for solution+diluent	454,219 L.L
J01DD07	CEFIZOX	B	Ceftizoxime (sodium) - 1g	1g	Injectable powder for solution	788,836 L.L
L01BC05	GEMCITABINE THYMOORGAN	G	Gemcitabine (HCl) - 1g	1g	Injectable powder for solution	5,843,027 L.L
L01BC05	GEMNIL	G	Gemcitabine (HCl) - 1g	1g	Injectable powder for solution	3,369,013 L.L
A10BA02	MINOR	G	Metformin HCl - 1g	1g	Tablet	266,209 L.L
L01BC05	HAXANIT	G	Gemcitabine (HCl) - 1g	1g	Injectable lyophilised powder	6,829,408 L.L
A10BA02	DIAPHAGE	G	Metformin HCl - 1g	1g	Tablet, extended release	150,510 L.L
H02AB04	SOLU MEDROL	B	Methylprednisolone sodium succinate - 1g	1g	Injectable powder for solution	1,444,631 L.L
H02AB04	METHYL PREDNISOLONE VIATRIS 1G	G	Methylprednisolone (hemisuccinate) - 1g	1g	Injectable dry powder for solution	1,348,604 L.L
J01DE01	CEFEPIME LDP LABORATORIOS TORLAN	G	Cefepime - 1g	1g	Injectable powder for solution	5,933,065 L.L
J01DE01	CEFEPIME PANPHARMA	G	Cefepime - 1g	1g	Injectable powder for solution	5,933,065 L.L
J01DE01	SALAPIME	G	Cefepime - 1g	1g	Injectable powder for solution	618,168 L.L
J01DH02	MERONEM	B	Meropenem (trihydrate) - 1g	1g	Injectable powder for solution	10,398,061 L.L
J01DH02	ARCHIFAR	G	Meropenem - 1g	1g	Injectable powder for solution	6,443,725 L.L
J01DH02	AROPEM	G	Meropenem (trihydrate) - 1g	1g	Injectable powder for solution	995,723 L.L
J01DH02	AROPEM	G	Meropenem - 1g	1g	Injectable powder for solution	995,723 L.L
J01DH02	AROPEM	G	Meropenem - 1g	1g	Injectable sterile lyophilised powder for solution	995,723 L.L
J01DH02	AROPEM	G	Meropenem - 1g	1g	Injectable sterile lyophilised powder for solution	19,022,727 L.L
J01DH02	MEROLIN	G	Meropenem (trihydrate) - 1g	1g	Injectable powder for solution	2,402,668 L.L
J01DH02	MEROPENEM LABATEC	G	Meropenem (trihydrate) - 1g	1g	Injectable powder for solution	7,278,513 L.L
J01DH02	MEROPENEM MEDIS	G	Meropenem (trihydrate) - 1g	1g	Injectable powder for solution	6,443,725 L.L
J01DH02	MEROPENEM PANPHARMA	G	Meropenem (trihydrate) - 1g	1g	Injectable powder for solution	7,278,513 L.L
J01DH02	MEROPENEM/ ANFARM	G	Meropenem (trihydrate) - 1g	1g	Injectable powder for solution	6,443,725 L.L
J01DH02	MEROZAN	G	Meropenem - 1g	1g	Injectable powder for solution	6,443,725 L.L
J01DH02	MIRAN	G	Meropenem (trihydrate) - 1g	1g	Injectable powder for solution	819,744 L.L

National Cancer Registry (NCR)